Cancer clinical trials in the region Île-de-France
787 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04752722
#2024-512900-20-00
Required histologic types
Non-invasive bladder cancer
Required histologic sub types
Urothelial carcinoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
2
3 or more
Excluded previous treatments at localized stage
Systemic Treatment-Naive
6 recruiting sites
enGene, Inc.
Phase 1 / Phase 2
Lung cancer
#NCT05443126
#2022-501636-42-00
Cohorte CBNPC RET Fusion-Positif naïf de traitement par inhibiteurs sélectifs de RET de première génération
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
RET
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Chemotherapy
Targeted therapy
5 recruiting sites
Ellipses Pharma
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04752722
#2024-512900-20-00
Required histologic types
Non-invasive bladder cancer
Required histologic sub types
Urothelial carcinoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
1
Required previous treatments at localized stage
Systemic Treatment-Naive
Immunotherapy
6 recruiting sites
enGene, Inc.
Phase 1 / Phase 2
Pancreas cancer
#NCT04657068
#2024-511534-12-00
Dose d'expansion Partie B6
Required histologic sub types
Adenocarcinoma
Other
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
ATM
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
7 recruiting sites
Artios Pharma Ltd
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT04657068
#2024-511534-12-00
Dose d'expansion Partie B5
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required genetic anomalies
ATM
Required number of previous lines of therapy for current stage of disease
1
2
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
7 recruiting sites
Artios Pharma Ltd
Phase 1 / Phase 2
Lung cancer
#NCT07407933
#2025-523742-27-00
Required histologic types
SCLC (Small Cell Lung Cancer)
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
3 recruiting sites
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1 / Phase 2
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT04657068
#2024-511534-12-00
Dose d'expansion Partie B2
Required histologic types
Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer (PPC)
Required histologic sub types
Serous high grade carcinoma (HGSOC)
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at localized stage
Chemotherapy
Targeted therapy
Required previous treatments at advanced or metastatic stage
Chemotherapy
Targeted therapy
Excluded previous treatments at localized stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
7 recruiting sites
Artios Pharma Ltd
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
#NCT04657068
#2024-511534-12-00
Dose d'expansion Partie B4
Required disease stage
Locally Advanced
Metastatic
Metastatic Castration-resistant
Required genetic anomalies
ATM
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
7 recruiting sites
Artios Pharma Ltd
Phase 1 / Phase 2
Endometrial cancer
#NCT04657068
#2024-511534-12-00
Dose d'expansion Partie B3
Required disease stage
Locally Advanced
Metastatic
Required genetic anomalies
ATM
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
7 recruiting sites
Artios Pharma Ltd
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
Head and neck cancer
#NCT04657068
#2024-511534-12-00
Dose d'expansion Partie B1
Required disease stage
Locally Advanced
Metastatic
Metastatic Castration-resistant
Required genetic anomalies
ATM
Required number of previous lines of therapy for current stage of disease
1
2
3 or more
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
7 recruiting sites
Artios Pharma Ltd